Ultrasound-guided Thyroid Cartilage Plane Block for Awake Intubation
Launched by NANJING FIRST HOSPITAL, NANJING MEDICAL UNIVERSITY · Sep 26, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to help patients who need a breathing tube placed while they are awake. The method being tested is called the Thyroid Cartilage Plane Block, which uses ultrasound to guide the injection of a local anesthetic (numbing medicine) near the thyroid cartilage, a part of the throat. The goal is to see if this method is effective and safe for helping patients feel more comfortable during the procedure, particularly those who have a difficult airway due to conditions like limited neck movement or facial deformities.
To participate in this study, patients should be between 18 and 65 years old and scheduled for surgery that requires awake intubation. They must also have specific challenges that make intubation harder. Participants will be divided into two groups: one will receive the new ultrasound-guided approach, while the other will get a traditional spraying method for numbing. Throughout the trial, researchers will look at how long the procedures take, how well patients tolerate the breathing tube, and how comfortable they feel during and after the intubation process. This study is currently recruiting participants, and it aims to improve the experience for patients needing this type of care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients scheduled for awake tracheal intubation surgery under general anesthesia.
- • 2. Patients with difficult airways (e.g., limited cervical spine mobility, full stomach, partial airway obstruction, craniofacial deformities or trauma, micrognathia, mouth opening \<3cm, Mallampati III or IV classification) posing challenges for mask ventilation or intubation.
- • 3. Age between 18 and 65 years.
- • 4. Gender is not restricted.
- • 5. ASA classification of I or II.
- Exclusion Criteria:
- • 1. Cardiovascular dysfunction or arterial aneurysms.
- • 2. Mental or neurological disorders or concomitant arterial aneurysms.
- • 3. Infection at the puncture site.
- • 4. Allergy to local anesthetics.
- • 5. Continuous use of antiplatelet or anticoagulant medications preoperatively.
- • 6. Hoarseness or coughing while drinking water.
- • 7. Bronchial asthma.
- • 8. Participation in other clinical trials within the previous 3 months before enrollment 9.r current participation in other clinical trials.
About Nanjing First Hospital, Nanjing Medical University
Nanjing First Hospital, affiliated with Nanjing Medical University, is a leading medical institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care and cutting-edge medical practices, the hospital serves as a key player in the development of new therapies and treatment protocols. Its collaborative environment fosters interdisciplinary research, enabling the integration of scientific inquiry with clinical application. Nanjing First Hospital is committed to improving health outcomes and contributing to the global medical community through rigorous trial design and execution, ensuring the highest standards of ethical practice and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nanjing, Nanjing, China
Patients applied
Trial Officials
Tao Shan
Study Chair
Nanjing First Hospital, Nanjing Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported